- Home
- LNT vs HOLX Comparison
LNT vs HOLX Comparison
Compare LNT & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNT
- HOLX
- Stock Information
- Founded
- LNT 1917
- HOLX 1985
- Country
- LNT United States
- HOLX United States
- Employees
- LNT N/A
- HOLX N/A
- Industry
- LNT Power Generation
- HOLX Medical Electronics
- Sector
- LNT Utilities
- HOLX Health Care
- Exchange
- LNT Nasdaq
- HOLX Nasdaq
- Market Cap
- LNT 15.9B
- HOLX 16.3B
- IPO Year
- LNT N/A
- HOLX 1990
- Fundamental
- Price
- LNT $61.11
- HOLX $56.18
- Analyst Decision
- LNT Hold
- HOLX Buy
- Analyst Count
- LNT 8
- HOLX 14
- Target Price
- LNT $63.19
- HOLX $79.00
- AVG Volume (30 Days)
- LNT 1.8M
- HOLX 3.9M
- Earning Date
- LNT 05-08-2025
- HOLX 05-01-2025
- Dividend Yield
- LNT 3.32%
- HOLX N/A
- EPS Growth
- LNT N/A
- HOLX 25.36
- EPS
- LNT 2.69
- HOLX 2.39
- Revenue
- LNT $3,981,000,000.00
- HOLX $4,026,500,000.00
- Revenue This Year
- LNT $10.40
- HOLX $3.34
- Revenue Next Year
- LNT $4.78
- HOLX $5.43
- P/E Ratio
- LNT $22.70
- HOLX $23.19
- Revenue Growth
- LNT N/A
- HOLX 1.66
- 52 Week Low
- LNT $49.05
- HOLX $51.90
- 52 Week High
- LNT $66.54
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- LNT 48.55
- HOLX 43.96
- Support Level
- LNT $60.20
- HOLX $51.90
- Resistance Level
- LNT $62.17
- HOLX $57.51
- Average True Range (ATR)
- LNT 1.26
- HOLX 1.57
- MACD
- LNT 0.11
- HOLX -0.10
- Stochastic Oscillator
- LNT 69.71
- HOLX 56.32
About LNT Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electric customers and 425,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.